{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "14008 Heavy Menstrual Bleeding 3.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "MANAGEMENT OF HEAVY MENSTRUAL BLEEDING"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "14008"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Gynaecologists"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "21 May 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "20 May 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "NICE HMB Guideline"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "9,12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women's and Children's"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Mr Spencer, Consultant Gynaecologist"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u221a MEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Miss Thakur, Clinical Director"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "24 May 2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Document Ratification Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "21 May 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: June 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Trust Intranet/ Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "14008 Heavy Menstrual Bleeding 3.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 13,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Ros Bullen-Bell"
                    },
                    {
                        "text": "Head of Midwifery"
                    },
                    {
                        "text": "24 May 2020"
                    },
                    {
                        "text": "Miss Dutta"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Miss Joshi"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Miss Rao"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Mr Gangooly"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Mr Partington"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Miss Sharma"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Mr Fiadjoe"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Miss Kausar"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Lavina DiSouza"
                    },
                    {
                        "text": "Matron For Gynaecology services"
                    },
                    {
                        "text": "Joanne Luck"
                    },
                    {
                        "text": "Senior Sister Gynaecology Outpatients"
                    },
                    {
                        "text": "Claire Fitzgerald"
                    },
                    {
                        "text": "Pharmacist"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) 04071 Standard Infection Prevention 04072 Hand Hygiene 06036 Guideline for Maternity Record Keeping including Documentation in Handheld Records 08014 Management of women requiring antenatal thromboprophylaxis 04184 Blood transfusion policy 04272 Maternity Care"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 13,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Mr Spencer, Dr Mistry, Dr Field"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "27 March 2014"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Mr Spencer"
                    },
                    {
                        "text": "Clarification to Appendix B"
                    },
                    {
                        "text": "20 March 2017"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Mr Spencer"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "30 August 2017"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Mr Spencer"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "21 May 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose ......................................................................................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality and Diversity .................................................................................................. 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Scope ............................................................................................................................. 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Definition of Heavy Menstrual Bleeding ..................................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "History, examination and investigations .................................................................... 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Pharmaceutical Treatment ........................................................................................... 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Surgical Treatment ....................................................................................................... 6  Patient Counselling\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026.\u2026.7"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Infection Prevention ..................................................................................................... 7  Audit and Monitoring\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u20268  References\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...\u2026\u20268 Appendix A - Assessment and Treatment Flow Chart\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u20269 Appendix B - Mid Essex Threshold Approval for Hysterectomy Criteria\u2026\u2026\u2026\u2026\u2026..10 Appendix C - Threshold Approval for Hysterectomy Criteria\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026....13 Appendix D - Preliminary Equality Analysis\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...14"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "HMB (Heavy Menstrual Bleeding) is a common problem affecting women throughout their reproductive years. In the majority of cases, no underlying pathology is found and the condition responds well to simple treatments. Ensuring that women are investigated appropriately is essential, as is a logical, step-wise approach to treatment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "This guideline is intended to guide those working in both primary and secondary care to ensure that women are optimally assessed, investigated and treated."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality and Diversity"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Mid and South Essex NHS Foundation Trust is committed to provision of a service that is fair, accessible, and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix D)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Scope"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "This guideline is an addition to and should be read in conjunction with the NICE guideline on Heavy Menstrual Bleeding."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Definition of Heavy Menstrual Bleeding"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Excessive menstrual blood loss interfering with physical, emotional, social and material quality of life."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "Measuring menstrual loss is not routinely recommended. Diagnosis should be based on the woman's perception of menstrual loss and the degree to which it affects her quality of life."
            }
        },
        {
            "type": "table",
            "sequence_num": 27,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "HMB"
                    },
                    {
                        "text": "Heavy Menstrual Bleeding"
                    },
                    {
                        "text": "LNG IUS"
                    },
                    {
                        "text": "levonorgestrel-releasing intrauterine system"
                    },
                    {
                        "text": "USS"
                    },
                    {
                        "text": "Ultra Sound Scan"
                    },
                    {
                        "text": "VE"
                    },
                    {
                        "text": "Vaginal Examination"
                    },
                    {
                        "text": "D & C"
                    },
                    {
                        "text": "Dilatation & Curettage"
                    },
                    {
                        "text": "COCP"
                    },
                    {
                        "text": "Combined oral contraceptive pill"
                    },
                    {
                        "text": "UAE"
                    },
                    {
                        "text": "uterine artery embolisation"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "History, examination and investigations"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "History taking"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "text": "To cover the nature of the bleeding, related symptoms such as pain, impact on quality of life, previous treatments tried and co-morbidities. If a woman has a history of Heavy Menstrual Bleeding without other related symptoms, consider pharmacological treatment without carrying out a physical examination unless the treatment chosen is the levonorgestrel-releasing intrauterine system (LNG IUS)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Features suggestive of structural/histological abnormalities include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "text": "Intermenstrual or postcoital bleeding;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "Pelvic pain;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "Pressure symptoms."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Examine prior to:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "text": "Insertion of LNG IUS;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "text": "Investigations for suspected structural/histological abnormalities."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Blood tests:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "text": "Full blood count in all women with HMB;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "Clotting screen for those with HMB since menarche or personal/family history suggestive of clotting disorder;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "text": "Thyroid function tests only if other signs and symptoms of thyroid disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "USS (Ultrasound Screening) Imaging:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "text": "Uterus palpable per abdomen"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "VE (vaginal examination) reveals pelvic mass of uncertain origin"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "Pharmaceutical treatment fails"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "text": "Intermenstrual bleeding or erratic menstrual cycle"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "text": "Patient build making clinical assessment difficult"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "Endometrial Biopsy:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "text": "To exclude endometrial cancer or atypical hyperplasia;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "text": "Persistent inter-menstrual bleeding;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "text": "Women > 45 years of age;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "Ineffective treatment/treatment failure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "Other Investigations:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "text": "Hysteroscopy should be used for diagnostic purposes when ultrasound is inconclusive and in many cases can be done as an outpatient procedure. Outpatient hysteroscopy guidance is detailed in a separate MEHT document."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "Dilatation & Curettage (D & C) alone should not be used as an investigative tool"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Pharmaceutical Treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "If history does not suggest structural or histological abnormality, then st line treatment may be commenced without further investigation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Consider pharmaceutical treatment as st line if, after investigation, no structural or histological abnormality is found, or if fibroids less than 3cm not distorting the cavity."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "If hormonal treatment is not acceptable (e.g. those wishing to avoid contraception) then use Tranexamic 1 gm TDS +/- Mefenamic acid 500 mg TDS orally."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "If either hormonal or non-hormonal treatments are acceptable then consider, in this order:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "text": "Mirena IUS providing at least 12 months use is anticipated;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "Combined oral contraceptive pill (COCP) or Tranexamic acid/Mefenamic acid;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "text": "Progestogen only pills such as Cerazette (Cerelle) or Noriday"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "text": "."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "Mefenamic acid should be added to Tranexamic acid if dysmenorrhoea is a problem."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 6.6,
                "text": "Choice of COCP:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "Usually standard dose oestrogen with nd generation progestagen is st line: e.g. Microgynon  or Loestrin 30;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "text": "Can use low dose oestrogen if risk factors for cardiovascular disease: e.g. Gedarel 20/150 or Millinette 20/75;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "text": "Phasic preparations can be used if breakthrough bleeding is problematic. e.g. TriRegol or Logynon;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "text": "Qlaira is a phasic preparation containing oestradiol valerate rather than ethinyloestradiol. It is licensed both for HMB and as a contraceptive, with evidence that withdrawal bleeding is both shorter and lighter."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "prefix": 6.6,
                "text": "Depo-provera or the progesterone-only implant (Nexplanon) are not licensed for HMB, however reduction in menstrual flow or amenorrhoea with continued use is widely reported."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "prefix": 6.7,
                "text": "Continue to use Mefenamic/Tranexamic acid as long as beneficial but stop using if no benefit after 3 cycles."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 6.8,
                "text": "If starting treatment prior to completing investigations, use Tranexamic acid +/- Mefenamic acid."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "If st line pharmaceutical treatment has failed can try other pharmaceutical methods before resorting to surgery"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "GnRH analogues (with add back HRT) can be used prior to surgery or when all other treatment for uterine fibroids are contraindicated or when a patient is suitable for conservative management of uterine fibroids. Those women in the peri-menopausal age group would be most suitable for this treatment regimen."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "prefix": 6.11,
                "text": "Do not use danazol routinely in HMB or luteal phase-only progestogens"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Surgical Treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "Endometrial ablation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "Consider if HMB having severe effect on quality of life and no desire to conceive in"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "text": "future;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "text": "May be offered as an initial treatment or after failed medical treatment;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "text": "Can be done in the presence of small (< 3cm) intramural uterine fibroids;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "In women with a history of Caesarean section, consideration should be given to performing an ultrasound with subsequent assessment of myometrial thickness at the level of the scar \u2018niche'. If this thickness is less than 8mm, the risk of thermal injury to nearby structures, e.g. the bladder, may be increased;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "text": "Advise to avoid subsequent pregnancy and use contraception."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "Fibroid Surgery"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "If large fibroids, HMB and other significant symptoms e.g. dysmenorrhoea or pressure symptoms, can use uterine artery embolisation (UAE) or surgery as st line;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "text": "UAE, trans-cervical resection of fibroids or abdominal myomectomy may allow preservation of fertility;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "text": "Prior to surgery or UAE do an ultrasound to assess size and location. If further detail required, proceed to MRI;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "text": "Consider pre-treatment with GnRH analogues for 3-4 months before myomectomy or hysterectomy where fibroids are enlarging or distorting the uterus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 1,
                "prefix": 7.3,
                "text": "Hysterectomy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Should not be used as st line treatment solely for HMB;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "When done solely for heavy menstrual bleeding may only be done under threshold approval:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "text": "Consider when"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "text": "Discuss risks and implications of hysterectomy including that there is a higher rate of operative complications when fibroids are present;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "Discuss possible loss of ovarian function even if ovaries are retained at surgery"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "Individual assessment when deciding route:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "st line surgical approach is usually vaginal, followed by total laparoscopic or abdominal depending on operator experience;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "If need for oophorectomy at time of vaginal hysterectomy consider laparoscopic approach;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "text": "Do not remove healthy ovaries at hysterectomy but consider removing fallopian tubes to reduce the future risk of ovarian cancer development;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "text": "Some women have chronic pelvic pain or severe PMS and are offered GnRH analogues before hysterectomy to switch off ovarian function. If this provides significant symptom relief, then bilateral salpingo-oophorectomy should be considered after discussion with the patient regarding the pros and cons. The patient should also be counselled about the possible need for oestrogen replacement after surgical menopause."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Patient counselling"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "All women should be given information on potentially unwanted outcomes following both medical and surgical interventions for HMB. These are summarised in Appendix B."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Infection Prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "All staff should follow Trust guidelines on infection prevention by ensuring that they effectively \u2018decontaminate their hands' before and after each procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 1,
                "prefix": 9.2,
                "text": "All invasive devices must be inserted and cared for using High Impact Intervention guidelines to reduce the risk of infection and deliver safe care. This care should be recorded in the Saving Lives High Impact Intervention Monitoring Tool Paperwork (Medical Devices)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Audit of compliance with this guideline will be undertaken on an annual audit basis in accordance with the Clinical Audit Strategy and Policy. The Audit Lead in liaison with the Risk Management Group will identify a lead for the audit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "The findings of the audit will be reported to and approved by the Multi-disciplinary"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "text": "Risk Management Group (MRMG) and an action plan with named leads and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "text": "timescales will be developed to address any identified deficiencies. Performance against the action plan will be monitored by this group at subsequent meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "The audit report will be reported to the monthly Directorate Governance Meeting (DGM) and significant concerns relating to compliance will be entered on the local Risk Assurance Framework."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "Key findings and learning points from the audit will be submitted to the Patient Quality and Safety Committee (PSQC) within the integrated learning report."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "Key findings and learning points will be disseminated to relevant staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "text": "Medicines and Healthcare Products Regulatory Agency (2011) Guidance on the responsibilities of manufacturers, the regulator and clinicians with respect to endometrial ablation. The recommendations of a joint workshop. MRHA: February."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "Heavy Menstrual Bleeding: assessment and management. Nice Clinical Guideline (NG 88) published th March 2018."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "text": "Service Restriction Policy. Mid Essex Clinical Commissioning Group (2013) British National Formulary. www.bnf.org"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "Heavy Menstrual Bleeding/ 14008 / 3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 1,
                "text": "Pathway for Management of Heavy Menstrual Bleeding (HMB) in Secondary Care   Appendix A"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "text": "Peri/pre-menopausal women referred with Hx of HMB History and examination + Ultrasound +/- endometrial biopsy Endometrial atypia"
            }
        },
        {
            "type": "image",
            "sequence_num": 122,
            "data": {
                "url": "14008 Heavy Menstrual Bleeding 3.0.003.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "text": "Submucous fibroids or endometrial polyp  Solitary (> 5cm) fibroid"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "text": "Fibroid uterus > 12/40 +/- pressure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "text": "Fertility not   symptoms"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "text": "desired"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "text": "Hysteroscopy/polypectomy/fibroid resection Fertility Normal U/S or intramural fibroids < 3cm +/- Mirena +/- ablation desired"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 1,
                "text": "Medical Treatment Surgical Treatment Myomectomy Uterine Artery"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 1,
                "text": "Re-ablation   Embolisation Hysterectomy +/- BSO If appropriate**"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "text": "Tranexamic acid/mefenamic acid  Endometrial ablation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "text": "LNG IUS   Failed ablation/Mirena"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "text": "COCP"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "text": "POP"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "text": "Injectable progestogens"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 1,
                "text": "GnRH analogues  Vaginal Hysterectomy  Laparoscopic hysterectomy Abdominal Hysterectomy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "text": "Uterus < 12 weeks size"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 1,
                "text": "*Vaginal hysterectomy should be first line but if not feasible then laparoscopic hysterectomy should be"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 1,
                "text": "considered in order to avoid abdominal approach. Normal ovaries should not be removed unless easily in postmenopausal women who request this."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 1,
                "text": "** If uterine cavity has visible and smooth endometrium such that access is possible and Asherman's likelihood low."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 1,
                "text": "Women who request hysterectomy as a first line treatment without evidence of pelvic pathology should receive a second gynaecological opinion. Reference: Heavy menstrual bleeding: NICE Guideline 44, January 2007."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 1,
                "text": "Appendix B"
            }
        },
        {
            "type": "table",
            "sequence_num": 142,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Treatment"
                    },
                    {
                        "text": "Potential unwanted outcomes experienced by some women (Common: 1 in 100 chance; less common: 1 in 1000 chance; rare: 1 in 10,000 chance; very rare: 1 in 100,000 chance)."
                    },
                    {
                        "text": "Levonorgestrel-releasing intrauterine system"
                    },
                    {
                        "text": "Common: irregular bleeding that may last for over 6 months; hormone-related problems such as breast tenderness, acne or headaches, which, if present, are generally minor and transient. Less common: amenorrhoea. Rare: uterine perforation at the time of insertion."
                    },
                    {
                        "text": "Tranexamic acid"
                    },
                    {
                        "text": "Less common: indigestion; diarrhoea; headaches."
                    },
                    {
                        "text": "Non-steroidal anti-inflammatory drugs"
                    },
                    {
                        "text": "Common: indigestion; diarrhoea. Rare: worsening of asthma in sensitive individuals; peptic ulcers with possible bleeding and peritonitis."
                    },
                    {
                        "text": "Combined oral contraceptives"
                    },
                    {
                        "text": "Common: mood changes; headaches; nausea; fluid retention; breast tenderness. Very rare: deep vein thrombosis; stroke; heart attacks."
                    },
                    {
                        "text": "Oral progestogen (norethisterone)"
                    },
                    {
                        "text": "Common: weight gain; bloating; breast tenderness; headaches; acne (but all are usually minor and transient). Rare: depression."
                    },
                    {
                        "text": "Injected progestogen"
                    },
                    {
                        "text": "Common: weight gain; irregular bleeding; amenorrhoea; premenstrual-like syndrome (including bloating, fluid retention, breast tenderness). Less common: small loss of bone mineral density, largely recovered when treatment discontinued."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 143,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Gonadotrophin-releasing hormone analogue"
                    },
                    {
                        "text": "Common: menopausal-like symptoms (such as hot flushes, increased sweating, vaginal dryness). Less common: osteoporosis, particularly trabecular bone with longer than 6-months' use."
                    },
                    {
                        "text": "Endometrial ablation"
                    },
                    {
                        "text": "Common: vaginal discharge; increased period pain or cramping (even if no further bleeding); need for additional surgery. Less common: infection. Rare: perforation (but very rare with second generation techniques)."
                    },
                    {
                        "text": "Uterine artery embolisation"
                    },
                    {
                        "text": "Common: persistent vaginal discharge; post-embolisation syndrome \u2013 pain, nausea, vomiting and fever (not involving hospitalisation). Less common: need for additional surgery; premature ovarian failure particularly in women over 45 years old; haematoma. Rare: haemorrhage; non-target embolisation causing tissue necrosis; infection causing septicaemia."
                    },
                    {
                        "text": "Myomectomy"
                    },
                    {
                        "text": "Less common: adhesions (which may lead to pain and/or impaired fertility); need for additional surgery; recurrence of fibroids; perforation (hysteroscopic route); infection. Rare: haemorrhage."
                    },
                    {
                        "text": "Hysterectomy"
                    },
                    {
                        "text": "Common: infection. Less common: intraoperative haemorrhage; damage to other abdominal organs, such as the urinary tract or bowel; urinary dysfunction \u2013 frequent passing of urine and incontinence. Rare: thrombosis (DVT and clot on the lung). Very rare: death. (Complications are more likely when hysterectomy is performed in the presence of fibroids.)"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 144,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Oophorectomy at time of hysterectomy"
                    },
                    {
                        "text": "Common: menopausal-like symptoms."
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 0,
                "text": "Heavy Menstrual Bleeding/ 14008 / 3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "text": "Heavy Menstrual Bleeding/ 14008 / 3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 1,
                "text": "Appendix C"
            }
        },
        {
            "type": "image",
            "sequence_num": 149,
            "data": {
                "url": "14008 Heavy Menstrual Bleeding 3.0.004.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 1,
                "text": "Mid Essex Threshold Approval for Hysterectomy Criteria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "text": "Heavy Menstrual Bleeding/ 14008 / 3.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 1,
                "text": "Appendix D: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Heavy menstrual bleeding/14008"
            }
        },
        {
            "type": "table",
            "sequence_num": 155,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "3 year Review"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and Clinicians"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 157,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Rachel Smith"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Specialist Nurse for Guidelines and Audit"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "05/05/2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 0,
                "prefix": 15.0,
                "text": ""
            }
        }
    ]
}